Jonathan J Hue

19PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyMolecular targetsPredictive and prognostic markersFood properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 21, 2026
Increased Glucose Availability Sensitizes Pancreatic Cancer to Macrophage-Targeting Immunotherapies.

|Jun 06, 2024
IDH1 Inhibition Potentiates Chemotherapy Efficacy in Pancreatic Cancer.

Mehrdad Zarei, Omid Hajihassani, Jonathan J Hue

|Oct 27, 2022
Management of adenocarcinoma of the pancreatic tail in the elderly.

Christina S Boutros, Jonathan J Hue, Mohamedraed Elshami

|Oct 03, 2022
IDO1 Is a Therapeutic Target for Pancreatic Cancer-Associated Depression.

Jonathan J Hue, Hallie J Graor, Mehrdad Zarei

|Apr 26, 2022
Prodromal depression and anxiety are associated with worse treatment compliance and survival among patients with pancreatic cancer.

Nathaniel E Davis, Jonathan J Hue, Ravi K Kyasaram

|Jan 25, 2022
ASO Author Reflection: Post-pancreatectomy Weight Trends Predict Recurrence and Survival.

Jonathan J Hue, Jordan M Winter, Sarah C Markt

Pageof 4

Frequent Collaborators

4 joint publications

Jordan M Winter

4 joint publications

John B Ammori

3 joint publications

Ali Vaziri-Gohar

3 joint publications

Omid Hajihassani